Does continuous glucose monitoring reduce acute kidney injury in adults with type 2 diabetes? A systematic review and meta-analysis
Published
July 11, 2025
Paper ID
PAP-000213
Status
Published
DOI
10.65712/tmj.test000471
Advance Services
Abstract
Background: acute kidney injury remains a leading cause of avoidable harm among adults with type 2 diabetes. Methods: Missing data were handled with multiple imputation. Results: 2834 participants were included (median age 72 years). 366 participants were included (median age 82 years). Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Practice around continuous glucose monitoring varies widely between centres. Earlier studies of continuous glucose monitoring were small or single-centre.
acute kidney injury remains a leading cause of avoidable harm among adults with type 2 diabetes. Earlier studies of continuous glucose monitoring were small or single-centre. Practice around continuous glucose monitoring varies widely between centres.
Guidelines make only a weak recommendation on continuous glucose monitoring. Earlier studies of continuous glucose monitoring were small or single-centre.
The cost of acute kidney injury to health systems is substantial. Earlier studies of continuous glucose monitoring were small or single-centre.
Materials and Methods
We conducted a systematic review and meta-analysis across 2 centres between 2017 and 2024. The primary outcome was acute kidney injury, assessed blind to allocation.
Eligible participants were adults with type 2 diabetes. Missing data were handled with multiple imputation. The primary outcome was acute kidney injury, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was acute kidney injury, assessed blind to allocation. Eligible participants were adults with type 2 diabetes.
We conducted a systematic review and meta-analysis across 8 centres between 2014 and 2021. Eligible participants were adults with type 2 diabetes.
Results
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. 799 participants were included (median age 77 years). 2671 participants were included (median age 28 years).
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % |
|---|---|---|---|
| Centre B | 413 | 9 | 4.4 |
| Control | 324 | 75 | 3.4 |
| Female | 604 | 95 | 19.6 |
| Female | 327 | 58 | 1.0 |
| Control | 397 | 22 | 18.8 |
Values are n (%) unless stated otherwise.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. 4093 participants were included (median age 39 years).
Discussion
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. These findings suggest that continuous glucose monitoring is associated with better acute kidney injury in adults with type 2 diabetes. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Implementation will depend on staffing, cost and local protocols. Future work should test continuous glucose monitoring in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. Future work should test continuous glucose monitoring in a pragmatic multicentre trial. These findings suggest that continuous glucose monitoring is associated with better acute kidney injury in adults with type 2 diabetes. Implementation will depend on staffing, cost and local protocols.
Conclusions
Continuous glucose monitoring may be offered for adults with type 2 diabetes to improve acute kidney injury.
References
1. Andersen S, Novak C, et al. Pharmacist-led medication review and length of stay. BMJ. 2018;73(9):15-1129.
2. Andersen D, Volkov R, et al. Tranexamic acid and patient satisfaction. JAMA. 2023;382(2):295-1489.
3. Kaur G, Nakamura L, et al. Point-of-care ultrasound and time to diagnosis. Lancet. 2016;85(6):882-1727.
4. Haddad S, Patel C, et al. A sepsis alert system and patient satisfaction. Crit Care Med. 2016;307(8):220-988.
5. Zhang W, Nakamura H, et al. Early enteral nutrition and acute kidney injury. N Engl J Med. 2010;167(2):329-1688.
6. Farouk B, Nasser C, et al. High-flow nasal oxygen and acute kidney injury. N Engl J Med. 2019;344(9):854-1062.
Appendices
Supplementary tables are available on request.